CLARITEV CORP (CTEV) Fundamental Analysis & Valuation

NYSE:CTEV • US62548M2098

Current stock price

24.33 USD
+0.52 (+2.18%)
Last:

This CTEV fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

4

1. CTEV Profitability Analysis

1.1 Basic Checks

  • In the past year CTEV has reported negative net income.
  • CTEV had a positive operating cash flow in the past year.
  • In the past 5 years CTEV reported 4 times negative net income.
  • CTEV had a positive operating cash flow in each of the past 5 years.
CTEV Yearly Net Income VS EBIT VS OCF VS FCFCTEV Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2019 2020 2021 2022 2023 2024 2025 0 -500M -1B -1.5B

1.2 Ratios

  • CTEV has a Return On Assets of -5.82%. This is in the better half of the industry: CTEV outperforms 61.76% of its industry peers.
  • Looking at the Return On Invested Capital, with a value of 0.77%, CTEV is in the better half of the industry, outperforming 67.65% of the companies in the same industry.
  • The Average Return On Invested Capital over the past 3 years for CTEV is significantly below the industry average of 7.46%.
Industry RankSector Rank
ROA -5.82%
ROE N/A
ROIC 0.77%
ROA(3y)-13.03%
ROA(5y)-9.12%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)1.44%
ROIC(5y)2.39%
CTEV Yearly ROA, ROE, ROICCTEV Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2019 2020 2021 2022 2023 2024 2025 0 -500 -1K -1.5K

1.3 Margins

  • The Operating Margin of CTEV (4.67%) is better than 67.65% of its industry peers.
  • CTEV's Operating Margin has declined in the last couple of years.
  • With a decent Gross Margin value of 73.75%, CTEV is doing good in the industry, outperforming 76.47% of the companies in the same industry.
  • In the last couple of years the Gross Margin of CTEV has grown nicely.
Industry RankSector Rank
OM 4.67%
PM (TTM) N/A
GM 73.75%
OM growth 3Y-46.77%
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-3.12%
GM growth 5Y2.24%
CTEV Yearly Profit, Operating, Gross MarginsCTEV Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2019 2020 2021 2022 2023 2024 2025 0 50 -50 -100 -150

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

1

2. CTEV Health Analysis

2.1 Basic Checks

  • CTEV has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
  • Compared to 1 year ago, CTEV has more shares outstanding
  • The number of shares outstanding for CTEV has been reduced compared to 5 years ago.
  • CTEV has a worse debt/assets ratio than last year.
CTEV Yearly Shares OutstandingCTEV Yearly Shares OutstandingYearly Shares Outstanding 2019 2020 2021 2022 2023 2024 2025 200M 400M 600M
CTEV Yearly Total Debt VS Total AssetsCTEV Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2019 2020 2021 2022 2023 2024 2025 2B 4B 6B 8B

2.2 Solvency

  • Based on the Altman-Z score of -0.43, we must say that CTEV is in the distress zone and has some risk of bankruptcy.
  • CTEV has a Altman-Z score of -0.43. This is comparable to the rest of the industry: CTEV outperforms 47.06% of its industry peers.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Altman-Z -0.43
ROIC/WACC0.13
WACC5.79%
CTEV Yearly LT Debt VS Equity VS FCFCTEV Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2019 2020 2021 2022 2023 2024 2025 0 1B 2B 3B 4B 5B

2.3 Liquidity

  • A Current Ratio of 0.86 indicates that CTEV may have some problems paying its short term obligations.
  • CTEV has a worse Current ratio (0.86) than 88.24% of its industry peers.
  • CTEV has a Quick Ratio of 0.86. This is a bad value and indicates that CTEV is not financially healthy enough and could expect problems in meeting its short term obligations.
  • CTEV's Quick ratio of 0.86 is on the low side compared to the rest of the industry. CTEV is outperformed by 88.24% of its industry peers.
Industry RankSector Rank
Current Ratio 0.86
Quick Ratio 0.86
CTEV Yearly Current Assets VS Current LiabilitesCTEV Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2019 2020 2021 2022 2023 2024 2025 100M 200M 300M 400M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

4

3. CTEV Growth Analysis

3.1 Past

  • CTEV shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 75.83%, which is quite impressive.
  • CTEV shows a small growth in Revenue. In the last year, the Revenue has grown by 3.74%.
  • Measured over the past years, CTEV shows a small growth in Revenue. The Revenue has been growing by 0.58% on average per year.
EPS 1Y (TTM)75.83%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%42.86%
Revenue 1Y (TTM)3.74%
Revenue growth 3Y-3.66%
Revenue growth 5Y0.58%
Sales Q2Q%6.21%

3.2 Future

  • CTEV is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 8.24% yearly.
  • Based on estimates for the next years, CTEV will show a small growth in Revenue. The Revenue will grow by 4.08% on average per year.
EPS Next Y15.45%
EPS Next 2Y13.26%
EPS Next 3Y8.24%
EPS Next 5YN/A
Revenue Next Year2.95%
Revenue Next 2Y3.9%
Revenue Next 3Y4.08%
Revenue Next 5YN/A

3.3 Evolution

  • The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
CTEV Yearly Revenue VS EstimatesCTEV Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 200M 400M 600M 800M 1B
CTEV Yearly EPS VS EstimatesCTEV Yearly EPS VS EstimatesYearly EPS VS Estimates 2020 2021 2022 2023 2024 2025 2026 2027 2028 0 -20 -40 -60 -80

More info and screens

Find the best growth stocksShow best growing peers

1

4. CTEV Valuation Analysis

4.1 Price/Earnings Ratio

  • The Price/Earnings Ratio is negative for CTEV. In the last year negative earnings were reported.
  • Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for CTEV. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
CTEV Price Earnings VS Forward Price EarningsCTEV Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20 30 40 50

4.2 Price Multiples

  • Based on the Enterprise Value to EBITDA ratio, CTEV is valued a bit cheaper than the industry average as 79.41% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 10.16
CTEV Per share dataCTEV EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 -100 -200

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y13.26%
EPS Next 3Y8.24%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. CTEV Dividend Analysis

5.1 Amount

  • No dividends for CTEV!.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

CTEV Fundamentals: All Metrics, Ratios and Statistics

CLARITEV CORP

NYSE:CTEV (4/27/2026, 11:02:39 AM)

24.33

+0.52 (+2.18%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Technology
Earnings (Last)02-23
Earnings (Next)05-07
Inst Owners54.28%
Inst Owner Change0.23%
Ins Owners5.43%
Ins Owner Change33.95%
Market Cap412.88M
Revenue(TTM)965.41M
Net Income(TTM)-284.28M
Analysts83.64
Price Target42.84 (76.08%)
Short Float %12.79%
Short Ratio5.76
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-20.51%
Min EPS beat(2)-25.62%
Max EPS beat(2)-15.41%
EPS beat(4)1
Avg EPS beat(4)-15.51%
Min EPS beat(4)-25.62%
Max EPS beat(4)2.57%
EPS beat(8)3
Avg EPS beat(8)-192.91%
EPS beat(12)6
Avg EPS beat(12)-117.79%
EPS beat(16)7
Avg EPS beat(16)-215.93%
Revenue beat(2)2
Avg Revenue beat(2)1.27%
Min Revenue beat(2)0.29%
Max Revenue beat(2)2.26%
Revenue beat(4)4
Avg Revenue beat(4)1.73%
Min Revenue beat(4)0.29%
Max Revenue beat(4)2.51%
Revenue beat(8)4
Avg Revenue beat(8)-1.5%
Revenue beat(12)6
Avg Revenue beat(12)-1.17%
Revenue beat(16)7
Avg Revenue beat(16)-1.82%
PT rev (1m)-35.19%
PT rev (3m)-35.19%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-12.14%
EPS NY rev (1m)2.13%
EPS NY rev (3m)-1.84%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-2.84%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-0.79%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.43
P/FCF N/A
P/OCF 3.52
P/B N/A
P/tB N/A
EV/EBITDA 10.16
EPS(TTM)-16.82
EYN/A
EPS(NY)-14.22
Fwd EYN/A
FCF(TTM)-0.72
FCFYN/A
OCF(TTM)6.91
OCFY28.42%
SpS56.89
BVpS-10.25
TBVpS-263.07
PEG (NY)N/A
PEG (5Y)N/A
Graham Number0 (-100%)
Profitability
Industry RankSector Rank
ROA -5.82%
ROE N/A
ROCE 0.97%
ROIC 0.77%
ROICexc 0.77%
ROICexgc 11.13%
OM 4.67%
PM (TTM) N/A
GM 73.75%
FCFM N/A
ROA(3y)-13.03%
ROA(5y)-9.12%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)1.44%
ROIC(5y)2.39%
ROICexc(3y)1.45%
ROICexc(5y)2.45%
ROICexgc(3y)29.62%
ROICexgc(5y)68.36%
ROCE(3y)1.83%
ROCE(5y)3.03%
ROICexgc growth 3Y-55.02%
ROICexgc growth 5YN/A
ROICexc growth 3Y-41.46%
ROICexc growth 5YN/A
OM growth 3Y-46.77%
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-3.12%
GM growth 5Y2.24%
F-Score5
Asset Turnover0.2
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Debt/EBITDA 9.34
Cap/Depr 29.1%
Cap/Sales 13.42%
Interest Coverage 0.16
Cash Conversion 23.92%
Profit Quality N/A
Current Ratio 0.86
Quick Ratio 0.86
Altman-Z -0.43
F-Score5
WACC5.79%
ROIC/WACC0.13
Cap/Depr(3y)27.45%
Cap/Depr(5y)25.03%
Cap/Sales(3y)12.48%
Cap/Sales(5y)10.66%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)75.83%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%42.86%
EPS Next Y15.45%
EPS Next 2Y13.26%
EPS Next 3Y8.24%
EPS Next 5YN/A
Revenue 1Y (TTM)3.74%
Revenue growth 3Y-3.66%
Revenue growth 5Y0.58%
Sales Q2Q%6.21%
Revenue Next Year2.95%
Revenue Next 2Y3.9%
Revenue Next 3Y4.08%
Revenue Next 5YN/A
EBIT growth 1Y-54.83%
EBIT growth 3Y-48.72%
EBIT growth 5YN/A
EBIT Next Year1185.71%
EBIT Next 3Y140.66%
EBIT Next 5YN/A
FCF growth 1Y-16.85%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y9.02%
OCF growth 3Y-31.96%
OCF growth 5Y-20.84%

CLARITEV CORP / CTEV Fundamental Analysis FAQ

Can you provide the ChartMill fundamental rating for CLARITEV CORP?

ChartMill assigns a fundamental rating of 2 / 10 to CTEV.


What is the valuation status for CTEV stock?

ChartMill assigns a valuation rating of 1 / 10 to CLARITEV CORP (CTEV). This can be considered as Overvalued.


How profitable is CLARITEV CORP (CTEV) stock?

CLARITEV CORP (CTEV) has a profitability rating of 4 / 10.


What is the earnings growth outlook for CLARITEV CORP?

The Earnings per Share (EPS) of CLARITEV CORP (CTEV) is expected to grow by 15.45% in the next year.